This Meeting is Proceeding as Planned
COVID-19 Update

Home

OCPC 2022
The Official Partner of the Oncology Clinical Pathways Congress
Utilizing Clinical Pathways to Improve the Quality of Cancer Care.
Welcome Back to Boston!

Registration is now open for the 2022 in-person Congress taking place October 14-16. The landscape of cancer care is rapidly evolving and oncology pathways play a critical role in defining how we treat our patients. We are excited to be back in Boston for an informative and substantive three-day program. 

As the official congress of the Journal of Clinical Pathways, this meeting serves as a forum for those involved in all stages of the pathway development to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.

Join Us in Boston
Register for Early Bird Rates
What to Expect

The Oncology Clinical Pathways Congress is a one-of-a-kind opportunity for all of those in cancer care to gather together and make a positive impact on the future of patient care.

 

200+
Leading Cancer Organizations
30+
Expert Presenters
20+
Unmatched Educational Sessions
Highlights
View 2021 Meeting Highlights
Meet the Steering Committee
Robin T. Zon, MD, FACP, FASCO
Past Chair, ASCO Pathways Task Force
Physician Emeritus, Finance & Quality Chair
Michiana Hematology-Oncology, PC
Mishawaka, Indiana
Alan Balch, PhD
Chief Executive Officer
Patient Advocate Foundation
National Patient Advocate Foundation
Hampton, Virginia
Wui-Jin Koh, MD
Senior Vice President, Chief Medical Officer
National Comprehensive Cancer Network
Ft. Washington, Pennsylvania
Frederick M. Schnell, MD, FACP
Chief Medical Officer
National Cancer Treatment Alliance/Community Oncology Alliance
Washington, DC
Stephen B. Edge, MD, FACS, FASCO
Vice President, Healthcare Outcomes & Policy, Professor of Surgery and Oncology, Department of Surgical Oncology, Breast Service, Roswell Park Comprehensive Cancer Center, Professor of Surgery, Jacobs School of Medicine, University at Buffalo
Buffalo, New York
Mahek A. Shah, MD, MBA, MS
Physician Executive, Investor, and Advisor
Harvard Business School
Associate Faculty
Harvard School of Public Health and Brigham Health, Ariadne Labs
Boston, Massachusetts
Network With Pathway Pioneers

This is your chance to learn best practices and common pitfalls from those who have experienced the sourcing, design, implementation, and evaluation process through:

• Case-Based Presentations
• Roundtable Discussions
• Networking Activities

Who Should Attend?

This program is designed for healthcare professionals interested in learning how to implement, maintain, and measure treatment pathways.

Cancer Center Directors
Directors of Oncology Practice Programs
Oncologist & Hematologists
Pathway Development Executives
Commercial & Government Payers
Reimbursement Specialists
Specialty Pharmacists
HEOR Specialists
Nurse Navigators
Students, Residents & Fellows
I think this is the best conference of its kind as it relates to clinical pathways on the road to value-based care."

Dr. Frederick Schnell
Chief Medical Officer
Community Oncology Alliance

This meeting is a great place for clinicians to be interactive with their peers and to learn about the latest advances in not only pathways and their development but also how they're used in a practice setting."

Gordon Kuntz

A ‘cookie cutter’ approach to cancer care will impede our ability to personalize care and meet patient needs. Pathways need to demonstrate flexibility to capitalize on advances in medical treatment, reflect development with scientific evidence, and assure providers that they offer the best possible outcomes for the patient."

Robin Zon, MD, FACP, FASCO
Chair, ASCO Pathways Task Force
 

Keep Me Informed